Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Posts Earnings Results

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) released its quarterly earnings data on Thursday. The company reported $0.08 earnings per share (EPS) for the quarter, FiscalAI reports.

Oaktree Acquisition Corp. III Life Sciences Stock Down 0.7%

OACC stock opened at $10.63 on Friday. The stock’s 50 day simple moving average is $10.65 and its 200 day simple moving average is $10.60. Oaktree Acquisition Corp. III Life Sciences has a fifty-two week low of $10.04 and a fifty-two week high of $10.74.

Institutional Investors Weigh In On Oaktree Acquisition Corp. III Life Sciences

Several hedge funds and other institutional investors have recently modified their holdings of OACC. Radcliffe Capital Management L.P. raised its position in shares of Oaktree Acquisition Corp. III Life Sciences by 175.5% during the third quarter. Radcliffe Capital Management L.P. now owns 225,662 shares of the company’s stock worth $2,372,000 after purchasing an additional 143,749 shares during the period. Berkley W R Corp grew its position in Oaktree Acquisition Corp. III Life Sciences by 125.2% in the 3rd quarter. Berkley W R Corp now owns 223,645 shares of the company’s stock valued at $2,351,000 after purchasing an additional 124,315 shares during the period. Meteora Capital LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the 2nd quarter valued at $517,000. Clear Street LLC increased its stake in Oaktree Acquisition Corp. III Life Sciences by 265.1% during the 2nd quarter. Clear Street LLC now owns 22,000 shares of the company’s stock valued at $230,000 after purchasing an additional 15,975 shares in the last quarter. Finally, Readystate Asset Management LP acquired a new position in Oaktree Acquisition Corp. III Life Sciences during the third quarter worth $262,000.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC) is a special purpose acquisition company (“SPAC”) formed to pursue merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinations with one or more businesses in the life sciences sector. Incorporated as a Cayman Islands exempted company, OACC is sponsored by Oaktree Capital Management, a global alternative investment firm with a longstanding track record in credit strategies and private equity.